269 related articles for article (PubMed ID: 11513138)
1. Strategies for target cell recognition by natural killer cells.
Diefenbach A; Raulet DH
Immunol Rev; 2001 Jun; 181():170-84. PubMed ID: 11513138
[TBL] [Abstract][Full Text] [Related]
2. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity.
Diefenbach A; Jensen ER; Jamieson AM; Raulet DH
Nature; 2001 Sep; 413(6852):165-71. PubMed ID: 11557981
[TBL] [Abstract][Full Text] [Related]
3. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
[TBL] [Abstract][Full Text] [Related]
4. NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer.
Cerwenka A; Lanier LL
Tissue Antigens; 2003 May; 61(5):335-43. PubMed ID: 12753652
[TBL] [Abstract][Full Text] [Related]
5. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions.
Sutherland CL; Chalupny NJ; Cosman D
Immunol Rev; 2001 Jun; 181():185-92. PubMed ID: 11513139
[TBL] [Abstract][Full Text] [Related]
6. The NKG2D receptor and its ligands-recognition beyond the "missing self"?
Watzl C
Microbes Infect; 2003 Jan; 5(1):31-7. PubMed ID: 12593971
[TBL] [Abstract][Full Text] [Related]
7. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.
Diefenbach A; Jamieson AM; Liu SD; Shastri N; Raulet DH
Nat Immunol; 2000 Aug; 1(2):119-26. PubMed ID: 11248803
[TBL] [Abstract][Full Text] [Related]
8. UL16 binding proteins.
Cao W; He W
Immunobiology; 2004; 209(3):283-90. PubMed ID: 15518340
[TBL] [Abstract][Full Text] [Related]
9. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
Bauer S; Groh V; Wu J; Steinle A; Phillips JH; Lanier LL; Spies T
Science; 1999 Jul; 285(5428):727-9. PubMed ID: 10426993
[TBL] [Abstract][Full Text] [Related]
10. NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors.
Regunathan J; Chen Y; Wang D; Malarkannan S
Blood; 2005 Jan; 105(1):233-40. PubMed ID: 15328154
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the Ly49I natural killer cell receptor reveals variability in dimerization mode within the Ly49 family.
Dimasi N; Sawicki MW; Reineck LA; Li Y; Natarajan K; Margulies DH; Mariuzza RA
J Mol Biol; 2002 Jul; 320(3):573-85. PubMed ID: 12096910
[TBL] [Abstract][Full Text] [Related]
12. Ligands for natural killer cell receptors: redundancy or specificity.
Cerwenka A; Lanier LL
Immunol Rev; 2001 Jun; 181():158-69. PubMed ID: 11513137
[TBL] [Abstract][Full Text] [Related]
13. The innate immune response to tumors and its role in the induction of T-cell immunity.
Diefenbach A; Raulet DH
Immunol Rev; 2002 Oct; 188():9-21. PubMed ID: 12445277
[TBL] [Abstract][Full Text] [Related]
14. NKG2D-independent suppression of T cell proliferation by H60 and MICA.
Kriegeskorte AK; Gebhardt FE; Porcellini S; Schiemann M; Stemberger C; Franz TJ; Huster KM; Carayannopoulos LN; Yokoyama WM; Colonna M; Siccardi AG; Bauer S; Busch DH
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11805-10. PubMed ID: 16091471
[TBL] [Abstract][Full Text] [Related]
15. Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60.
O'Callaghan CA; Cerwenka A; Willcox BE; Lanier LL; Bjorkman PJ
Immunity; 2001 Aug; 15(2):201-11. PubMed ID: 11520456
[TBL] [Abstract][Full Text] [Related]
16. Promiscuity and the single receptor: NKG2D.
Eagle RA; Trowsdale J
Nat Rev Immunol; 2007 Sep; 7(9):737-44. PubMed ID: 17673918
[TBL] [Abstract][Full Text] [Related]
17. DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor.
Zhou H; Luo Y; Lo JF; Kaplan CD; Mizutani M; Mizutani N; Lee JD; Primus FJ; Becker JC; Xiang R; Reisfeld RA
Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10846-51. PubMed ID: 16040807
[TBL] [Abstract][Full Text] [Related]
18. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
Song H; Kim J; Cosman D; Choi I
Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
[TBL] [Abstract][Full Text] [Related]
19. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family.
Steinle A; Li P; Morris DL; Groh V; Lanier LL; Strong RK; Spies T
Immunogenetics; 2001; 53(4):279-87. PubMed ID: 11491531
[TBL] [Abstract][Full Text] [Related]
20. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts.
Ogasawara K; Benjamin J; Takaki R; Phillips JH; Lanier LL
Nat Immunol; 2005 Sep; 6(9):938-45. PubMed ID: 16086018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]